Total Funding
93
77
Total FundingVenture - Series Unknown raised
Growth Score
-1 pts
Heat Score
68 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
43644
Illexcor Therapeutics focuses on discovering and developing new oral treatments for sickle cell disease.
- Andrew Fleischman: CEO and Co-Founder
- Martin Safo: Co-Founder and CSO
About the Company
Illexcor Therapeutics is a biopharmaceutical firm dedicated to creating and developing groundbreaking oral treatments for sickle cell disease.
